TY - JOUR
T1 - Genetic Intratumor Heterogeneity Remodels the Immune Microenvironment and Induces Immune Evasion in Brain Metastasis of Lung Cancer
AU - Wang, Xin
AU - Bai, Hua
AU - Zhang, Jiyang
AU - Wang, Zhijie
AU - Duan, Jianchun
AU - Cai, Hongqing
AU - Cao, Zheng
AU - Lin, Qingtang
AU - Ding, Xiaosheng
AU - Sun, Yiting
AU - Zhang, Wei
AU - Xu, Xiaoya
AU - Chen, Hao
AU - Zhang, Dadong
AU - Feng, Xiaoli
AU - Wan, Jinghai
AU - Zhang, Jianjun
AU - He, Jie
AU - Wang, Jie
N1 - Publisher Copyright:
© 2023 International Association for the Study of Lung Cancer
PY - 2024/2
Y1 - 2024/2
N2 - Introduction: Brain metastasis, with the highest incidence in patients with lung cancer, significantly worsens prognosis and poses challenges to clinical management. To date, how brain metastasis evades immune elimination remains unknown. Methods: Whole-exome sequencing and RNA sequencing were performed on 30 matched brain metastasis, primary lung adenocarcinoma, and normal tissues. Data from The Cancer Genome Atlas primary lung adenocarcinoma cohort, including multiplex immunofluorescence, were used to support the findings of bioinformatics analysis. Results: Our study highlights the key role of intratumor heterogeneity of genomic alterations in the metastasis process, mainly caused by homologous recombination deficiency or other somatic copy number alteration–associated mutation mechanisms, leading to increased genomic instability and genomic complexity. We further proposed a selection model of brain metastatic evolution in which intratumor heterogeneity drives immune remodeling, leading to immune escape through different mechanisms under local immune pressure. Conclusions: Our findings provide novel insights into the metastatic process and immune escape mechanisms of brain metastasis and pave the way for precise immunotherapeutic strategies for patients with lung cancer with brain metastasis.
AB - Introduction: Brain metastasis, with the highest incidence in patients with lung cancer, significantly worsens prognosis and poses challenges to clinical management. To date, how brain metastasis evades immune elimination remains unknown. Methods: Whole-exome sequencing and RNA sequencing were performed on 30 matched brain metastasis, primary lung adenocarcinoma, and normal tissues. Data from The Cancer Genome Atlas primary lung adenocarcinoma cohort, including multiplex immunofluorescence, were used to support the findings of bioinformatics analysis. Results: Our study highlights the key role of intratumor heterogeneity of genomic alterations in the metastasis process, mainly caused by homologous recombination deficiency or other somatic copy number alteration–associated mutation mechanisms, leading to increased genomic instability and genomic complexity. We further proposed a selection model of brain metastatic evolution in which intratumor heterogeneity drives immune remodeling, leading to immune escape through different mechanisms under local immune pressure. Conclusions: Our findings provide novel insights into the metastatic process and immune escape mechanisms of brain metastasis and pave the way for precise immunotherapeutic strategies for patients with lung cancer with brain metastasis.
KW - Brain metastasis
KW - Immune editing
KW - Intra-tumor heterogeneity
KW - Patient-paired samples
KW - Precise immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=85174458833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85174458833&partnerID=8YFLogxK
U2 - 10.1016/j.jtho.2023.09.276
DO - 10.1016/j.jtho.2023.09.276
M3 - Article
C2 - 37717855
AN - SCOPUS:85174458833
SN - 1556-0864
VL - 19
SP - 252
EP - 272
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 2
ER -